
2.21BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
NL00150012L7
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
5.26
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.69
Wall Street Target Price
50.75
EPS Estimate Current Year
-1.35
EPS Estimate Next Year
-1.90
EPS Estimate Current Quarter
-0.4357
EPS Estimate Next Quarter
-0.3932
Most Recent Quarter
-
Revenue TTM
25,937,000
Gross Profit TTM
25,937,000
EBITDA
-233,204,000
Profit Margin
0.00%
Return On Assets TTM
-19.79%
Return On Equity TTM
-30.16%
Revenue Per Share TTM
0.212
Qtly Revenue Growth YOY
5406.90%
Diluted Eps TTM
-1.69
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
108
Price Sales TTM
85.1259
Price Book MRQ
3.7094
Enterprise Value Revenue
65
Enterprise Value EBITDA
27
965.00
0.00%128.26
0.00%390.94
-2.36%151.52
-2.31%925.70
-1.93%32.39
-1.88%318.32
-1.17%516.11
-1.04%917.00
-0.91%199.30
-0.11%